Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 6Unknown 4Completed 4Terminated 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 5Thoracic 4Head & Neck 4Genitourinary 4Other solid neoplasm 2Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1

Conditions

Solid Tumor, Adult 1Mesothelioma, Malignant 1Disease Progression 1

Interventions

pembrolizumab 27Pemetrexed 10Nivolumab 10Cyclophosphamide 10Carboplatin 10atezolizumab 8Specimen Handling 8Cisplatin 8Ipilimumab 6Biopsy 6fludarabine 5Injections 5tislelizumab 4spartalizumab 4Vincristine 4Radiotherapy 4Proton Therapy 4Platinum 4Paclitaxel 4Drug Therapy 4Docetaxel 4Bevacizumab 41,2-diaminocyclohexaneplatinum II citrate 4sintilimab 3durvalumab 3Trastuzumab 3Etoposide 3Cetuximab 3zimberelimab 2trametinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Interleukin-2 × Other solid neoplasm × Clear all
NCT04643574 2025-02-14

NeoTIL in Advanced Solid Tumors

Centre Hospitalier Universitaire Vaudois

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT03546426 2024-10-01

MESOVAX

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 1 Active not recruiting
18 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡